Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 17036
Country/Region: South Africa
Year: 2017
Main Partner: Foundation for Professional Development
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $27,837,483 Additional Pipeline Funding: $1,252,537

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $4,584,687
Care: TB/HIV (HVTB) $3,778,004
Care: Pediatric Care and Support (PDCS) $995,891
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $1,991,780
Treatment: Adult Treatment (HTXS) $15,491,230
Treatment: Pediatric Treatment (PDTX) $995,891
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 365,447
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 1,025,739
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2018 18,947
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2018 49,895
HTS_TST Service Delivery Point Agg Age (Facility) Inpatient: <15, Female, Negative 2018 2,036
HTS_TST Service Delivery Point Agg Age (Facility) Inpatient: <15, Male, Negative 2018 2,035
HTS_TST Service Delivery Point Agg Age (Facility) Inpatient: 15+, Female, Negative 2018 26,338
HTS_TST Service Delivery Point Agg Age (Facility) Inpatient: 15+, Male, Negative 2018 17,593
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: <15, Female, Negative 2018 1,700
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: <15, Male, Negative 2018 683
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 144,933
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 85,410
HTS_TST Service Delivery Point Agg Age (Facility) TB: <15, Female, Negative 2018 680
HTS_TST Service Delivery Point Agg Age (Facility) TB: <15, Male, Negative 2018 679
HTS_TST Service Delivery Point Agg Age (Facility) TB: 15+, Female, Negative 2018 16,841
HTS_TST Service Delivery Point Agg Age (Facility) TB: 15+, Male, Negative 2018 12,424
HTS_TST Service Delivery Point Agg Age (Facility) VCT: 15+, Female, Negative 2018 3,728
HTS_TST Service Delivery Point Agg Age (Facility) VCT: 15+, Male, Negative 2018 2,493
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Negative 2018 5,396
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Negative 2018 5,381
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Negative 2018 73,882
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Negative 2018 49,154
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Negative 2018 5,409
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Negative 2018 1,816
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 413,483
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 238,590
HTS_TST Service Delivery Point by Agg Age (Facility) TB: <15, Female, Negative 2018 1,808
HTS_TST Service Delivery Point by Agg Age (Facility) TB: <15, Male, Negative 2018 1,807
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Negative 2018 46,932
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Negative 2018 34,731
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Negative 2018 9,782
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Negative 2018 6,457
HTS_TST Sum of Test Result disaggregates 2018 27,621
HTS_TST Sum of Test Result disaggregates 2018 78,699
HTS_TST_POS By Test Result: Positive 2018 27,621
HTS_TST_POS By Test Result: Positive 2018 78,699
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2018 400
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2018 1,046
HTS_TST_POS Service Delivery Point Agg Age (Facility) Inpatient: <15, Female, Positive 2018 42
HTS_TST_POS Service Delivery Point Agg Age (Facility) Inpatient: <15, Male, Positive 2018 41
HTS_TST_POS Service Delivery Point Agg Age (Facility) Inpatient: 15+, Female, Positive 2018 2,130
HTS_TST_POS Service Delivery Point Agg Age (Facility) Inpatient: 15+, Male, Positive 2018 1,434
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: <15, Female, Positive 2018 193
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: <15, Male, Positive 2018 13
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 13,413
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 7,032
HTS_TST_POS Service Delivery Point Agg Age (Facility) TB: <15, Female, Positive 2018 10
HTS_TST_POS Service Delivery Point Agg Age (Facility) TB: <15, Male, Positive 2018 19
HTS_TST_POS Service Delivery Point Agg Age (Facility) TB: 15+, Female, Positive 2018 1,432
HTS_TST_POS Service Delivery Point Agg Age (Facility) TB: 15+, Male, Positive 2018 959
HTS_TST_POS Service Delivery Point Agg Age (Facility) VCT: 15+, Female, Positive 2018 309
HTS_TST_POS Service Delivery Point Agg Age (Facility) VCT: 15+, Male, Positive 2018 194
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Positive 2018 107
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Positive 2018 106
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Positive 2018 5,993
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Positive 2018 4,035
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Positive 2018 640
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Positive 2018 34
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 39,061
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 19,552
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: <15, Female, Positive 2018 37
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: <15, Male, Positive 2018 28
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Positive 2018 4,015
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Positive 2018 2,674
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Positive 2018 854
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Positive 2018 530
PMTCT_ART Already on ART at beginning of current pregnancy 2018 1,149
PMTCT_ART Already on ART at beginning of current pregnancy 2018 3,692
PMTCT_ART New on ART 2018 4,131
PMTCT_ART New on ART 2018 12,749
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 5,280
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 16,441
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 27,483
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 87,640
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 4,933
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 16,102
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 4,885
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 15,778
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 5
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 38
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 43
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 200
PMTCT_EID Unknown, 2 - 12 months 2018 86
PMTCT_STAT By Age (Numerator): : 15-19 2018 3,099
PMTCT_STAT By Age (Numerator): 10-14 2018 1,575
PMTCT_STAT By Age (Numerator): 10-14 2018 5,169
PMTCT_STAT By Age (Numerator): 15-19 2018 10,349
PMTCT_STAT By Age (Numerator): 20-24 2018 8,030
PMTCT_STAT By Age (Numerator): 20-24 2018 25,636
PMTCT_STAT By Age (Numerator): 25-49 2018 14,779
PMTCT_STAT By Age (Numerator): 25-49 2018 46,486
PMTCT_STAT By known positives: 10-14 2018 107
PMTCT_STAT By known positives: 15-19 2018 227
PMTCT_STAT By known positives: 20-24 2018 528
PMTCT_STAT By known positives: 25-49 2018 934
PMTCT_STAT By new negatives: <10 2018 208
PMTCT_STAT By new negatives: 10-14 2018 1,231
PMTCT_STAT By new negatives: 15-19 2018 2,483
PMTCT_STAT By new negatives: 20-24 2018 6,514
PMTCT_STAT By new negatives: 25-49 2018 11,993
PMTCT_STAT By new negatives: 50+ 2018 97
PMTCT_STAT By new positives: <10 2018 21
PMTCT_STAT By new positives: 10-14 2018 194
PMTCT_STAT By new positives: 15-19 2018 378
PMTCT_STAT By new positives: 20-24 2018 982
PMTCT_STAT By new positives: 25-49 2018 1,797
PMTCT_STAT By new positives: 50+ 2018 10
PMTCT_STAT By Number of known positives: 10-14 2018 416
PMTCT_STAT By Number of known positives: 15-19 2018 834
PMTCT_STAT By Number of known positives: 20-24 2018 1,867
PMTCT_STAT By Number of known positives: 25-49 2018 3,265
PMTCT_STAT By Number of new negative: 10-14 2018 4,121
PMTCT_STAT By Number of new negative: 15-19 2018 8,281
PMTCT_STAT By Number of new negative: 20-24 2018 20,679
PMTCT_STAT By Number of new negative: 25-49 2018 37,596
PMTCT_STAT By Number of new positives: 10-14 2018 607
PMTCT_STAT By Number of new positives: 15-19 2018 1,225
PMTCT_STAT By Number of new positives: 20-24 2018 3,075
PMTCT_STAT By Number of new positives: 25-49 2018 5,633
PMTCT_STAT By Number of new positives: 50+ 2018 12
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 27,483
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 87,640
PMTCT_STAT_den By Age (Denominator): <10 2018 1
PMTCT_STAT_den By Age (Denominator): <15-19 2018 10,550
PMTCT_STAT_den By Age (Denominator): 10-14 2018 1,575
PMTCT_STAT_den By Age (Denominator): 10-14 2018 5,283
PMTCT_STAT_den By Age (Denominator): 15-19 2018 3,158
PMTCT_STAT_den By Age (Denominator): 20-24 2018 8,263
PMTCT_STAT_den By Age (Denominator): 20-24 2018 26,151
PMTCT_STAT_den By Age (Denominator): 25-49 2018 15,093
PMTCT_STAT_den By Age (Denominator): 25-49 2018 47,441
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 291
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 659
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 3,716
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 1,671
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 185
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 434
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 1,090
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 2,452
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 3,605
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 8,069
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 3,247
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 7,261
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 832
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 322
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 4,120
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 1,852
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 483
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 205
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 2,723
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 1,226
TB_PREV By Age/Sex (Numerator): <15, Female 2018 360
TB_PREV By Age/Sex (Numerator): <15, Female 2018 1,029
TB_PREV By Age/Sex (Numerator): <15, Male 2018 238
TB_PREV By Age/Sex (Numerator): <15, Male 2018 689
TB_PREV By Age/Sex (Numerator): 15+, Female 2018 1,958
TB_PREV By Age/Sex (Numerator): 15+, Female 2018 5,827
TB_PREV By Age/Sex (Numerator): 15+, Male 2018 1,278
TB_PREV By Age/Sex (Numerator): 15+, Male 2018 3,895
TB_PREV By Therapy type (Numerator): 6-12 Month IPT 2018 3,838
TB_PREV By Therapy type (Numerator): 6-12 Month IPT 2018 11,471
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 3,838
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 11,471
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 7,431
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 21,509
TB_PREV_den By Age/Sex (Denominator): <15, Female 2018 673
TB_PREV_den By Age/Sex (Denominator): <15, Female 2018 1,945
TB_PREV_den By Age/Sex (Denominator): <15, Male 2018 450
TB_PREV_den By Age/Sex (Denominator): <15, Male 2018 1,290
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2018 3,803
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2018 10,970
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2018 2,506
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2018 7,304
TB_PREV_den By Therapy type (Denominator): 6-12 Month IPT 2018 7,418
TB_PREV_den By Therapy type (Denominator): 6-12 Month IPT 2018 21,509
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 416
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 1,191
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 2,353
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 6,745
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 272
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 802
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 1,543
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 4,476
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 4,592
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 13,214
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 4,628
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 13,416
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 417
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 1,207
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 2,354
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 6,760
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 275
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 815
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 1,551
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 4,553
TX_CURR Aggregated Age/Sex: <15 Female 2018 1,977
TX_CURR Aggregated Age/Sex: <15 Female 2018 11,611
TX_CURR Aggregated Age/Sex: <15 Male 2018 2,044
TX_CURR Aggregated Age/Sex: <15 Male 2018 11,714
TX_CURR Aggregated Age/Sex: 15+ Female 2018 63,019
TX_CURR Aggregated Age/Sex: 15+ Female 2018 352,791
TX_CURR Aggregated Age/Sex: 15+ Male 2018 27,018
TX_CURR Aggregated Age/Sex: 15+ Male 2018 152,440
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 94,058
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 528,557
TX_CURR Sum of Aggregated Age/Sex <15 2018 4,021
TX_CURR Sum of Aggregated Age/Sex <15 2018 23,325
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 90,037
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 505,231
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 94,058
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 528,556
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2018 533
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2018 2,522
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 599
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 2,607
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 26,843
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 103,933
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 11,527
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 44,570
TX_NEW Breastfeeding status 2018 21
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 39,502
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 153,632
TX_NEW Pregnancy status 2018 9,538
TX_NEW Pregnancy status 2018 34,688
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 39,502
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 153,632
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 96,213
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 454,921
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 86,599
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 409,420
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 1,823
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 8,687
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 1,883
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 8,759
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 58,001
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 273,287
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 24,892
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 117,114
TX_PVLS Numerator: Indication: Routine 2018 86,599
TX_PVLS Numerator: Indication: Routine 2018 409,420
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Routine 2018 1,187
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 2,007
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 9,665
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 2,076
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 9,755
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 64,484
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 304,562
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 27,646
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 130,636
TX_PVLS_den Denominator: Indication: Routine 2018 58,975
TX_PVLS_den Denominator: Indication: Routine 2018 262,959
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Routine 2018 1,489
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Routine 2018 1,065
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 978
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 5,619
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 1,012
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 5,674
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 31,355
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 170,705
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 13,442
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 73,155
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 46,887
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 256,113
TX_RET Numerator by Status: Pregnant 2018 5,620
TX_RET Numerator by Status: Pregnant 2018 30,637
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 118,104
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 455,059
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 1,722
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 7,588
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 1,923
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 7,835
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 80,124
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 307,698
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 34,335
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 131,929
TX_RET_den Denominator by Status: Pregnant 2018 14,166
TX_RET_den Denominator by Status: Pregnant 2018 54,634
Cross Cutting Budget Categories and Known Amounts Total: $360,000
Gender: Gender Based Violence (GBV) $80,000
GBV Prevention
Implementation
Capacity building
Monitoring and Evaluation
Operation Research
Collection and Use of Gender-related Strategic Information
Capacity building
Gender: Gender Equality $80,000
Equity in HIV prevention, care, treatment and support
Gender: Gender Based Violence (GBV) $80,000
GBV Prevention
Implementation
Capacity building
Monitoring and Evaluation
Operation Research
Collection and Use of Gender-related Strategic Information
Capacity building
Human Resources for Health $120,000